--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About ALEC20261016C2.5
Chemical and pharmaceutical
Alector, Inc., originally incorporated as a limited liability company in Delaware in May 2013, is a clinical-stage biopharmaceutical company. Groundbreaking immuno-neurology, a new treatment for neurodegeneration. Immunoneurology identifies immune dysfunction as the underlying cause of a variety of pathologies that are drivers of degenerative encephalopathy. They are developing therapies designed to counteract these conditions at the same time by restoring healthy immune function to the brain.
